KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2023-08-30
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, multicenter, phase III clinical study to compare
the clinical efficacy and safety of KN046 plus paclitaxel and carboplatin versus placebo plus
paclitaxel and carboplatin in subjects with advanced squamous NSCLC who have not previously
received systemic treatment.